Dietary Supplement Boosts CAR T
This is a news story, published by ScienceBlog.com, that relates primarily to Abramson Cancer Center news.
Abramson Cancer Center news
For more Abramson Cancer Center news, you can click here:
more Abramson Cancer Center newsNews about keto, paleo, vegan, mediterranean
For more keto, paleo, vegan, mediterranean news, you can click here:
more keto, paleo, vegan, mediterranean newsScienceBlog.com news
For more news from ScienceBlog.com, you can click here:
more news from ScienceBlog.comAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about keto, paleo, vegan, mediterranean, you might also like this article about
Cellular Immunotherapies. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest dietary interventions news, cancer cells news, news about keto, paleo, vegan, mediterranean, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
own immune cellsScienceBlog.com
•Keto diet metabolite may power up CAR T cells to kill cancer
92% Informative
A simple dietary supplement may provide a new approach to boost CAR T cell function.
Beta-hydroxybutyrate, a metabolite produced by the liver in response to a ketogenic diet, was a key mediator of this effect.
CAR T cells prefer BHB as a fuel source rather than standard sugars in our body, such as glucose.
The BHB supplement is being tested in a clinical trial at Penn Medicine’s Abramson Cancer Center .
The study was partly funded by the Penn -CHOP Microbiome Core.
Liu will present the findings during the Plenary Scientific Session on Sunday, Dec. 8 at 2 p.m. PT.
Patients interested in clinical trials at the Abramson Cancer Center can search open clinical trials here.
VR Score
94
Informative language
95
Neutral language
67
Article tone
formal
Language
English
Language complexity
70
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
18
Source diversity
8
Affiliate links
no affiliate links